Jeff Yass’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-62,400
Closed -$8.51M 12072
2020
Q3
$8.51M Sell
62,400
-23,000
-27% -$2.45M ﹤0.01% 2376
2020
Q2
$8.25M Sell
85,400
-125,800
-60% -$10.5M ﹤0.01% 2367
2020
Q1
$9.9M Buy
211,200
+160,500
+317% +$10.3M ﹤0.01% 1751
2019
Q4
$3.69M Sell
50,700
-19,300
-28% -$1.17M ﹤0.01% 3396
2019
Q3
$3.65M Buy
70,000
+14,000
+25% +$744K ﹤0.01% 3185
2019
Q2
$2.81M Sell
56,000
-21,500
-28% -$1.05M ﹤0.01% 3551
2019
Q1
$4.03M Buy
77,500
+36,000
+87% +$1.66M ﹤0.01% 2714
2018
Q4
$2.03M Buy
41,500
+9,200
+28% +$506K ﹤0.01% 3499
2018
Q3
$2.11M Sell
32,300
-14,700
-31% -$864K ﹤0.01% 3897
2018
Q2
$2.33M Sell
47,000
-65,400
-58% -$3.17M ﹤0.01% 3757
2018
Q1
$5.49M Buy
112,400
+97,300
+644% +$5.06M ﹤0.01% 2431
2017
Q4
$636K Buy
+15,100
New +$582K ﹤0.01% 6157

Jeff Yass's MYOK Position: Q4 2020 in Review

Jeff Yass sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 20,088 shares — an estimated $2.74M sold.

Jeff Yass first reported a position in MYOK in Q4 2015 and held it in 10 quarters. The position peaked at $8.61M in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Jeff Yass reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Jeff Yass sold 20,088 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.74M.
  • Jeff Yass first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 10 quarters.
  • Jeff Yass's MyoKardia, Inc. Common Stock position peaked at $8.61M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.